Incidence and outcome of mild cognitive impairment in a population-based prospective cohort
- PMID: 12451203
- DOI: 10.1212/01.wnl.0000034176.07159.f8
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort
Abstract
Objective: To estimate the age-specific incidence rate of mild cognitive impairment (MCI) according to sex and educational level and to explore the course of MCI, particularly its progression to AD, in a population-based cohort.
Methods: A community-based cohort of nondemented elderly people (Personnes Agées QUID [PAQUID]) was followed longitudinally for 5 years. MCI was defined as memory complaints with objective memory impairment, without dementia, impairment of general cognitive functioning, or disability in activities of daily living. Incidence rates were calculated using the person-years method. A descriptive analysis at the different follow-up times was performed to study the course of MCI.
Results: At baseline, there were 58 prevalent cases of MCI (2.8% of the sample). During a 5-year follow-up, 40 incident cases of MCI occurred in 1,265 subjects at risk. The global incidence rate of MCI was 9.9/1,000 person-years. MCI was a good predictor of AD with an annual conversion rate of 8.3% and a good specificity, but it was very unstable over time: Within 2 to 3 years, only 6% of the subjects continued to have MCI, whereas >40% reverted to normal.
Conclusions: Conventionally defined MCI has reasonable predictive value and specificity for AD. However, MCI was very unstable across time in this study. Furthermore, the definition of MCI seems to be too restrictive and should probably be extended to other categories of individuals also at high risk of developing AD.
Similar articles
-
Frequency and course of mild cognitive impairment in a multiethnic community.Ann Neurol. 2008 Apr;63(4):494-506. doi: 10.1002/ana.21326. Ann Neurol. 2008. PMID: 18300306 Free PMC article.
-
Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.Dement Geriatr Cogn Disord. 2004;18(1):87-93. doi: 10.1159/000077815. Epub 2004 Apr 14. Dement Geriatr Cogn Disord. 2004. PMID: 15087583 Clinical Trial.
-
Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.Arch Gerontol Geriatr. 2007;44 Suppl 1:233-41. doi: 10.1016/j.archger.2007.01.032. Arch Gerontol Geriatr. 2007. PMID: 17317458
-
Mild cognitive impairment and the 7 uses of epidemiology.Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S52-7. doi: 10.1097/00002093-200607001-00007. Alzheimer Dis Assoc Disord. 2006. PMID: 16917196 Review.
-
The impact of mild cognitive impairment on functional abilities in the elderly.Curr Psychiatry Rep. 2002 Feb;4(1):64-8. doi: 10.1007/s11920-002-0015-8. Curr Psychiatry Rep. 2002. PMID: 11814398 Review.
Cited by
-
Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial.Iran J Pharm Res. 2023 Oct 30;22(1):e138943. doi: 10.5812/ijpr-138943. eCollection 2023 Jan-Dec. Iran J Pharm Res. 2023. PMID: 38444714 Free PMC article.
-
Prevalence and associated factors of mild cognitive impairment among middle-aged and older adults: Results of the first phase of Ardakan Cohort Study on Aging.Health Sci Rep. 2024 Jan 22;7(1):e1827. doi: 10.1002/hsr2.1827. eCollection 2024 Jan. Health Sci Rep. 2024. PMID: 38264157 Free PMC article.
-
Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigm.BMJ Open. 2023 Oct 18;13(10):e080101. doi: 10.1136/bmjopen-2023-080101. BMJ Open. 2023. PMID: 37852774 Free PMC article.
-
The impact of cognitive impairment in urologic implants: a narrative review.Transl Androl Urol. 2023 Sep 30;12(9):1426-1438. doi: 10.21037/tau-23-226. Epub 2023 Sep 5. Transl Androl Urol. 2023. PMID: 37814692 Free PMC article. Review.
-
Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity.Alzheimers Res Ther. 2023 Oct 5;15(1):167. doi: 10.1186/s13195-023-01317-3. Alzheimers Res Ther. 2023. PMID: 37798677 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources